KPP
AMGN icon

Kings Path Partners’s Amgen AMGN Stock Holding History

Kings Path Partners’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.09K Buy
+3
New +$1.03K ﹤0.01% 317
2025
Q1 		– Sell
-3,789
Closed -$988K – 260
2024
Q4 		$988K Sell
3,789
-579
-13% -$172K 0.42% 61
2024
Q3 		$1.41M Hold
4,368
– – 0.59% 38
2024
Q2 		$1.36M Buy
+4,368
New +$1.28M 0.64% 36

Other funds holding AMGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
AWA
Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

Kings Path Partners's AMGN Position: Q2 2026 in Review

Kings Path Partners opened a new position in Amgen (AMGN) in Q2 2026: 3 shares worth $1.09K. The stake represents ﹤0.01% of the portfolio and ranks #317 among its holdings. This is a return to the name: Kings Path Partners previously reported a position in AMGN as recently as Q4 2024.

Kings Path Partners first reported a position in AMGN in Q2 2024 and has held it in 4 quarters since. The position peaked at $1.41M in Q3 2024. 748 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Kings Path Partners held 3 shares of Amgen worth $1.09K as of Q2 2026.
  • Amgen was a new Kings Path Partners position in Q2 2026.
  • Amgen made up ﹤0.01% of Kings Path Partners's portfolio in Q2 2026, its #317 holding.
  • Kings Path Partners first reported a position in Amgen in Q2 2024 and has held it in 4 quarters since.
  • Kings Path Partners's Amgen position peaked at $1.41M in Q3 2024.
  • 748 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Kings Path Partners's 13F filing for Q2 2026, filed 14 Jul 2026.